Clinical Trial 42502

share

Upland, CA 91786


Study Summary:

A phase 3, multicenter, randomized, double-blind, placebo-controlled study evaluationgthe efficacy and safety of bimekizumab in subjects with active Nonradiographic Axial Spondyloarthritis.


Qualified Participants Must:

• Subject is male or female at least 18 years of age
• Inflamatory back pain for at least 3 months prior to screening visit
• Age at symptoms onset prior to age 45
• Inadequate response to NSAID therapy or intolerance to administration of at least 1 NSAID
• Subjects must have active disease as defined by both of the following visits screening and baseline.


Qualified Participants May Receive:

Free study medication if qualify and enrolled into the study. Free doctor visits along with blood results. Once you are qualified and enrolled into study you will receive $40.00 per visit completed.


Study is Available At:

Inland Rheumatology Clinical Trials, Inc.
1238 E. Arrow Hwy
Upland, CA 91786
View Clinic Location

 


If you or someone you care for is interested in participating in this clinical trial and lives within 50 miles of the clinic, please complete the form below and click 'I Am Interested In This Study'

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.